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Abstract 
Objective: While adolescent anxiety disorders represent prevalent, debilitating 
conditions, few studies explore their brain physiology.  Using event-related functional 
MRI (fMRI) and a behavioral measure of attention to angry faces, we evaluated 
differences in response between healthy adolescents and adolescents with generalized 
anxiety disorder (GAD).   
Method:  In the primary trials of interest, 18 adolescents with GAD and 15 comparisons 
of equivalent age/gender/IQ viewed angry/neutral face pairs during fMRI acquisition.  
Following the presentation of each face pair, subjects pressed a button to a probe that was 
either on the same (congruent) or opposite (incongruent) side as the angry face.  Reaction 
time differences between congruent and incongruent face-trials provided a measure of 
attention bias to angry faces.   
Results: Relative to controls, patients with GAD manifested greater right ventrolateral 
prefrontal cortex (VLPFC) activation to trials containing angry faces.  Compared with 
controls, patients with GAD also showed greater attentional bias away from angry faces.  
VLPFC activation differences were independent of differences in attentional bias. 
Conclusions: Adolescents with GAD show greater right VLPFC activation and 
attentional bias away from angry faces than controls.  Enhanced VLPFC engagement 
may directly relate to anxiety, or may regulate abnormal functioning in another region.   
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Introduction 
Adolescent generalized anxiety disorder (GAD) predicts high risk for adult GAD, 
social phobia, and major depressive disorder (MDD) (1).  While only one study (2) 
explores neurophysiological correlates of GAD in youth, considerable data both in the 
basic sciences and adult anxiety disorder literature form the basis for hypotheses about 
the roles of specific neural structures in adolescent GAD (3-12).   
Basic research implicates a neural circuit including the amygdala and ventral 
prefrontal cortex (VPFC) in threat monitoring and response (5, 9, 10).  The VPFC, in 
particular, the ventrolateral PFC (VLPFC), modulates amygdala engagement to facilitate 
flexible attention and behavior when responding to environmental threats (3-6, 9).  
Anxiety disorders may relate to perturbations in this VPFC-amygdala circuit.  The only 
available study in anxious youth selectively imaged the amygdala in ten patients and ten 
controls and reported that patients relative to controls showed greater response to threat-
related facial expressions (2).  Among adults, patients with anxiety disorders showed 
increased amygdala activation and abnormal VPFC responses (8, 12-15).  These neural 
abnormalities may disrupt the regulatory processes of vigilance and attention to threat-
related stimuli. 
Increased vigilance and perturbed attention are prominent features of pediatric 
and adult anxiety disorders (16-23).  Thus, brain-based differences between anxious 
patients and controls may reflect anxiety-related differences in attentional processes.  For 
example, anxious patients relative to controls may shift attention away from threatening 
stimuli, which could either reflect or affect between-group differences in brain activation.  
Therefore, when examining between group differences in neural responses, it may be 
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advantageous to monitor attention and examine effects of attention on between-group 
differences in activation.   
The visual probe task provides an index of threat-related perturbations in attention 
(16, 17, 20-22).  In the visual probe task, adult patients with GAD and other anxiety 
disorders orient attention towards angry “threat” faces more strongly than healthy adults 
(21-23).  Interestingly, in a visual probe study of children with post-traumatic stress 
disorder (PTSD), findings were opposite to those in adults: pediatric patients displayed a 
greater attentional bias away from threat, in comparison with healthy children (16).  
While preliminary, these findings suggest that anxiety disorders may involve systematic 
disruptions in threat biases that vary across development.   
For the present fMRI investigation, we used the visual probe task to examine 
differences between adolescents with GAD and healthy adolescents.  Consistent with 
prior studies, we hypothesized that adolescents with GAD would show abnormal VPFC 
activation and increased amygdala activation relative to controls in response to angry 
faces.  We also hypothesized that adolescents with GAD would exhibit abnormal 
attentional bias to angry faces.   
 
Methods 
Participants  
 Thirty-three adolescents participated in this study.  Health and cognitive status of 
all participants was determined with a physical examination and an IQ test.  The Kiddie 
Schedule for Affective Disorders and Schizoprenia (24) was administered by trained 
clinicians.  Based on an independent study, each clinician had been shown to have 
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excellent reliability (κ>.75) with senior clinicians for all diagnoses.  Group demographics 
are provided in Table 1.  The NIMH IRB approved all procedures, and all 
adolescents/parents provided written assent/consent.     
 The primary inclusion criterion was a diagnosis of GAD in an adolescent (9-17 
years of age); the GAD diagnosis had to be the explicit focus of treatment.  Other 
inclusion criteria were similar to those in published studies of pediatric anxiety disorders 
(25-27).  Specifically, these included: (1) clinically significant symptoms of anxiety 
based on a Pediatric Anxiety Rating Scale score (PARS) ≥10 (28); (2) Children’s Global 
Assessment Scale score <60 (29); (3) desire for outpatient treatment; (4) persistent 
anxiety based on the PARS over a 3-week period during which supportive 
psychoeducational therapy was provided  
 Exclusion criteria included: (1) current use of any psychoactive substance; for 
patients, usage of any psychoactive substance since the onset of the anxiety disorder; (2) 
current Tourette’s syndrome, obsessive-compulsive disorder, PTSD, conduct disorder, 
exposure to extreme trauma, or suicidal ideation; (3) lifetime history of mania, psychosis, 
or pervasive developmental disorder; (4) IQ less than 70.  MDD was not considered 
exclusionary, since longitudinal and family-based studies note strong relationships 
between adolescent GAD and MDD.  Secondary fMRI analyses compared activation 
between groups with and without MDD as well as social phobia to determine the degree 
to which comorbidity moderated findings in patients with GAD.   
  
Visual Probe Task 
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 We used the same procedures and stimuli as previously described (30) (See 
Figure 1).  Briefly, trials began with a 500 ms central fixation point.  Two faces then 
appeared for 500 ms.  These were replaced by an asterisk-probe in one hemi-field for 
1100 ms.  Participants were instructed to press one button with their thumb if the probe 
appeared on the left and a second button with their index finger if the probe appeared on 
the right.  The inter-trial interval was 1900 ms. Before scanning, participants were trained 
on the task.   
 Participants saw 80 actors, each presented twice, for a total of 160 trials (Figure 
1).  An additional 40 blank trials (no faces and no probes) were presented to serve as the 
primary comparison for documenting between-group differences in activation to the 
angry faces.   
For the behavioral measure of attention, there were two conditions of interest: (1) 
congruent trials – an angry/neutral face-pair, followed by a probe replacing the angry 
face; and (2) incongruent trials -- an angry/neutral face-pair followed by a probe 
replacing the neutral face.  Three other conditions were included as controls: congruent 
happy-neutral pairs, incongruent happy-neutral pairs, and neutral-neutral pairs.  There 
were 32 trials for each of the five conditions.  Trial presentation order was randomly 
determined for each subject.  Equal numbers of replicates displayed the emotional face on 
right and left hemi-fields.     
 The task was programmed using E-Prime versions 1.0 and 1.1 by Psychological 
Software Tools (Pittsburgh, PA) and displayed on Avotec Silent Vision Glasses (Stuart, 
FL).  The button response system was developed by MRI Devices (Waukesha, WI).   
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Functional MRI Procedures and Analyses 
Imaging used a GE 3T scanner to acquire images with 29 contiguous 3.3 mm 
axial slices, parallel to the AC/PC line.  We used an echo-planar single shot gradient echo 
T2* weighting (TR=2300 ms; TE=23 ms; FOV= 240 mm; 64 x 64 matrix; 3.3 x 3.75 x 
3.75 mm voxel).  High-resolution T1-weighted volumetric scans used a magnetization 
prepared gradient echo sequence (MP-RAGE) [180 1.0 mm axial slices; FOV=256 mm, 
NEX = 1, TR = 11.4 ms, TE = 4.4 ms; matrix = 256 x 256; TI = 300 ms, bandwidth 130 
Hz/pixel =33 kHz for 256 pixels in-plane resolution = 1 mm3].   
Functional imaging data were analyzed using AFNI software version 2.56b 
(available at http://afni.nimh.nih.gov/afni) (31).  Participants were excluded if there was 
movement greater than 2.5 mm in any direction.  Movement was mitigated by registering 
the images to one volume in each run.  Individuals’ data were smoothed with a 6 mm 
full-width at half-maximum isotropic Gaussian filter.  Incorrect trials and trials in which 
the reaction time for the button response was < 200 ms or > 800 ms were removed from 
the fMRI analysis.   
A random effects fMRI data analysis was conducted using a two level procedure.  
At the first (subject) level, data from each subject were separately submitted to multiple 
regression analyses using the 3dDeconvolve module in AFNI.  For the five conditions 
(angry congruent, angry incongruent, happy congruent, happy incongruent, and neutral), 
five vectors were created containing the onset time of each trial for each condition.  
(blank trials were modeled as an implicit baseline.)  Time points for trials in which the 
subject responded incorrectly or did not respond were placed in a separate vector 
included in the multiple regression model as a nuisance covariate.  Using a gamma 
 8 
variate (32), vectors of stimulus timing were transformed into reference waveforms of 
response function for multiple regression, and coefficients were produced for each 
condition from each subject.  Comparison of coefficients for given conditions yielded 
contrast values.  The primary effect of interest for the fMRI analysis was response to 
angry faces.  Therefore, contrasts were established to examine activation to angry faces 
relative to baseline.  Before individual subject data sets were subjected to a group level 
analysis, individual anatomical data sets were converted to Talairach space (33).  The 
underlying transformation was then applied to that same individual’s functional data in 
order to convert those images as well.  The second (group) level analysis involved 
conducting a regression analysis using the AFNI module 3DregAna on the main contrast 
of interest: angry vs. baseline trials to evaluate the neurophysiological response with age 
as a covariate following previous work (16).  For comparison, we used the same 
procedures to examine responses to happy faces vs. baseline and neutral faces vs. 
baseline.   
We employed two thresholds to evaluate the fMRI results.  For the first threshold, 
we used the standard whole-brain p < .001 2-tailed t-test uncorrected for multiple 
comparisons throughout the brain (34).  As a second step if activation in an area was 
significant at p < .001, we also used a Monte Carlo simulation (35) to control for multiple 
comparisons within the primary areas of interest, the ventral frontal area (anterior to 
anterior commissure and ventral to genu of corpus callosum) and the amygdala.  In the 
Monte Carlo simulation, each voxel surpassed a threshold of p<.01.   
 
Behavioral Data Analysis 
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The same deviant trials were removed as in the fMRI analysis.  Participants were 
excluded from data analysis if fewer than 75% of the responses were correct or within the 
accepted reaction time range.   
Attentional bias scores reflected the difference between mean reaction times for 
incongruent and congruent trials, such that positive values indicate bias toward angry 
faces and negative values indicate bias away from angry faces (16, 22).  A comparable 
analysis examined bias for happy faces.  An analysis of variance with age entered as a 
covariate was used to compare group differences in attentional bias, following previous 
work (16) and to be consistent with the fMRI analysis.   
 
Results 
The primary fMRI and behavioral analyses examined whether there were fMRI 
activation and reaction time differences between the GAD and control groups in response 
to angry faces.  In addition, we compared activation between groups for responses to 
happy and neutral faces.  Secondary analyses evaluated the degree to which differences in 
the primary analysis were influenced by either task performance or comorbidity.   
 
fMRI Results 
Differential activation between the groups was examined for the contrast of angry 
faces vs. baseline.  In this analysis, GAD adolescents showed greater activation in the 
right VLPFC, t(30) 3.91, p < .001 (Figure 2).  The Monte Carlo simulation was 
significant at p < .05 corrected for multiple comparisons of the region of interest.  No 
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effects in the amygdala were found.  No significant differences in activation were found 
between the two groups in response to either happy or neutral faces relative to baseline.   
 
Behavioral Results 
 Adolescents with GAD, relative to controls, showed a greater attentional bias 
away from angry faces, F(1, 30) = 4.90, p < .05.  For patients, attentional bias was –6.93 
ms (32.3), and for the controls the bias was 10.41 ms (21.0).  Mean ± sd reaction times 
(ms) were: 562.4 (55.0) for patients to congruent angry-face trials; 523.8 (89.9) for 
healthy controls to congruent angry-face trials; 555.5 (53.2) for patients to incongruent 
angry-face trials; and 534.1 (91.4) for healthy controls to incongruent angry-face trials.  
No between-group differences were found in reaction time overall to trials containing 
angry faces.  Furthermore, there were no between group differences in attention bias to 
happy faces and there were no between group differences in reaction time overall to trials 
with happy faces.   
 
Secondary fMRI Results  
Given that there were behavioral differences in attentional bias between groups, a 
secondary fMRI analysis included the attentional bias measure as a covariate.  In this 
analysis, the GAD group continued to show greater activation in the previously identified 
right VLPFC region t(29) = 3.78, p < .001.   
Nine GAD patients had MDD, and nine had no history of MDD.  We examined 
differences in VLPFC activation from controls separately in these two groups and relative 
to one another.  In order to maximize the likelihood that differences would be detected 
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between the GAD and GAD/MDD groups, we used uncorrected t tests and the values 
from the VLPFC cluster analysis presented in Figure 2b.  Both adolescents with GAD/no 
MDD and adolescents with GAD/MDD showed greater VLPFC activation relative to 
controls (GAD/no MDD vs. controls t(22)=2.89, p<.01; GAD/MDD vs. controls 
t(22)=4.22, p<.001), with no differences in VLPFC activation found between the two 
patient groups (t(16) = .59, p=.57).   
Furthermore, ten of the 18 GAD patients had social phobia.  To evaluate the effect 
of social phobia on VLPFC activation, we employed the same liberal cluster analysis as 
described with MDD to maximize the likelihood of finding differences.  Adolescents 
with GAD/no social phobia and adolescents with GAD/social phobia showed greater 
VLPFC activation relative to controls (GAD/no social phobia vs. controls t(23)=3.70, 
p<.01; GAD/social phobia vs. controls t(21)=3.22, p<.01), with no differences in VLPFC 
activation found between the two patient groups (t(16) = .35, p=.73). 
Finally, to examine the relationship between severity of anxiety symptoms and 
brain activation, we entered the patients’ PARS scores in a covariate analysis.  Results 
revealed a significant activation in the right VLPFC, t(16) = 3.98, p= .001 (Figure 2C).  
As severity of symptoms increased across patients, activation in the VLPFC diminished. 
 
Discussion 
In response to angry faces, adolescents with GAD, relative to healthy adolescents, 
exhibit greater activation in the right VLPFC.  Furthermore, adolescents with GAD show 
an attentional bias away from angry faces relative to healthy adolescents.  When the 
difference in attention was treated as a covariate in the fMRI analysis, the GAD patients 
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continued to show greater VLPFC activation relative to controls, suggesting that 
differences in attention do not account for differences in VLPFC engagement.  Contrary 
to our hypothesis, patients with GAD did not evidence greater amygdala activation than 
controls in response to angry faces.  Finally, there were no differences in response to 
happy or neutral faces.   
Abnormal activation in GAD adolescents’ VLPFC in the current study is 
consistent with previous neuroimaging work on adults with various anxiety disorders, 
including social phobia, PTSD, and panic disorder (7, 12, 13, 36), although the direction 
of the effects in previous studies is inconsistent.  In the present study, the enhanced GAD 
VLPFC activation suggests one of two possibilities: 1) a disturbance in functioning that 
may be a direct neural correlate of increased anxiety; or 2) a compensatory response 
designed to regulate abnormal function in another region.   
Support for the first possibility comes from a study of pediatric patients with 
traumatic brain injury (37).  This work revealed that greater damage to the VPFC was 
associated with reduced anxiety, suggesting that this region is involved in the 
manifestation of anxiety symptoms.  In the present study, angry faces may induce a 
modicum of anxiety among patients, and this is manifested as increased VLPFC 
activation.   
Concerning the second possibility, the VPFC is involved in various regulatory 
processes (9, 38, 39).  In particular, animal work demonstrates extensive connections 
between the VPFC and subcortical structures, including the striatum, amygdala and 
hippocampus, which are implicated in processing emotion-based information (40-42).  
Moreover, these connections facilitate VPFC regulation of subcortical structures (39, 40).  
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Similarly, imaging studies suggest that the VLPFC regulates activation in subcortical 
structures in adult humans as well (9, 43, 44).  Thus, it is possible that the VLPFC in the 
patients modulates abnormal activation in another region.  Differential between-group 
activation in the other region is not detected possibly because the VLPFC is effectively 
modulating the abnormal response.  The finding that increased VLPFC activation is 
associated with fewer anxiety symptoms is consistent with the possibility that the 
activation is compensatory.  Enhanced VLPFC activation may help GAD patients more 
effectively regulate initial responses to anxiety provoking stimuli, thereby reducing 
severity of symptoms.    
The observation of greater attentional bias away from threat in adolescent anxiety 
disorders replicates previous work in children with PTSD (16).  Both the current and the 
prior study document findings opposite from those found in adults.  Specifically, in adults 
studied with the same task, anxiety disorder patients exhibit a bias towards threat faces 
relative to neutral faces, compared with healthy adults (21, 22).  Thus, the relationship 
between anxiety and threat bias assessed with this task varies across development.  An 
important direction for future work will be to uncover the mechanisms that explain the 
developmental variation.  Monitoring eye gaze, varying intensity of threat and 
manipulating presentation duration may illuminate the variables that contribute to the 
developmental differences.   
The current findings illustrate the importance of behavioral measures and event-
related analyses in neuroimaging investigations of between-group differences.  We 
restricted our analyses to events where participants performed the task properly.  Thus, 
only trials in which participants were engaged in the task were included in the analyses.  
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Furthermore, because this task provides a measure of attention to angry faces, it was 
possible to evaluate whether the fMRI results were influenced by group differences in 
attention allocation to the angry faces.  When the attentional bias measure was included 
in the fMRI analysis as a covariate, the between group difference in VLPFC activation 
remained significant, indicating that attention differences do not account for these 
findings.  
A potential limitation of this study is that the clinical sample included GAD patients 
who were comorbid with MDD and/or social phobia.  To examine whether effects were 
differentially influenced by these other conditions, we examined the VLPFC activation 
within each of the clinical groups.  Whereas both clinical subgroups showed significantly 
increased VLPFC activation relative to controls in response to angry faces, the VLPFC 
activation did not differ between clinical subgroups.  These analyses suggest that the 
VLPFC activation was not disproportionately influenced by MDD or social phobia.   
A second limitation of the study is the broad age range in our relatively small 
sample, which precluded performance of an adequately powered analysis of effects 
across development within adolescents.  Replication in larger sample of younger and 
older adolescents will help to clarify the developmental progression of these findings and 
how they relate to anxiety.   
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Table 1. Demographics of the control and GAD samples.  Diagnoses refer to current or 
ongoing conditions.   
Variable Healthy Group Patient Group Statistical Comparison 
Sample 
Size 
15 18  
Gender 7 males; 8 females 10 males; 8 females X2(1) = .26 p > 1.0 
Age 13.53 (2.41) 12.28 (2.05) t(31) = 1.62 p p > 1.0 
IQ 115.13 (9.77) 109.00 (12.65) t(31) = 1.53 p > 1.0 
MDD 0 9  
Soc Phob 0 10  
SAD 0 8  
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Figure 1. The two principal trial types in the task.  In the left column, a sample trial 
displays the angry face and probe on different sides of the screen.  The same actor always 
models the two expressions.  The middle two columns display the duration of each event 
and the event name for both trial types.  The right column shows a sample trial when the 
angry face and probe are on the same side.  The only difference between the two trials is 
the location of the probe relative to the threat.  Happy/neutral and neutral/neutral trials 
were also displayed.   
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Figure 2.  a. In the comparison of trials in which the angry face appeared relative to the baseline condition 
(fixation followed by black screen), adolescents with GAD show greater activation than controls in the 
right VLPFC (right is left and left is right).  Coordinates (x y z) are 40 34 –12.  B. Mean blood oxygenation 
level-dependent (BOLD) response for adolescent controls and patients with GAD for the same contrast in 
the voxel cluster encompassing the activation in the right VLPFC.  C. BOLD response for patients in right 
VLPFC covaried by severity of anxiety symptoms (PARS), Pearson r = -.55, p<.05.  The location of the 
VLPFC cluster of activation (x y z coordinates 52 37 -9) is slightly different from the cluster in B.  GAD 
patients with and without MDD are differentiated in B and C.  
a.           b.  
 
C. 
 
